Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1978 1
1980 4
1981 9
1982 6
1983 16
1984 12
1985 24
1986 19
1987 45
1988 13
1989 47
1990 23
1991 36
1992 23
1993 10
1994 33
1995 14
1996 15
1997 18
1998 15
1999 8
2000 10
2001 12
2002 7
2003 9
2004 5
2005 3
2006 2
2007 5
2008 4
2009 3
2010 1
2011 3
2012 4
2013 2
2014 4
2015 4
2016 4
2019 3
2020 1
2021 1
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

471 results

Results by year

Filters applied: . Clear all
Page 1
Sucralfate--alternative therapy for peptic-ulcer disease.
Garnett WR. Garnett WR. Clin Pharm. 1982 Jul-Aug;1(4):307-14. Clin Pharm. 1982. PMID: 6764389 Review.
Sucralfate remains at the site of gastric ulcers for up to six hours. ...Sucralfate is FDA-approved for short-term (up to eight weeks) treatment of duodenal ulcers....
Sucralfate remains at the site of gastric ulcers for up to six hours. ...Sucralfate is FDA-approved for short-term (up to eigh
Sucralfate in gastritis.
Funch-Jensen P, Kristensen ES, Kruse A, Soerensen FH, Amdrup E. Funch-Jensen P, et al. Scand J Gastroenterol Suppl. 1987;127:93-6. doi: 10.3109/00365528709090958. Scand J Gastroenterol Suppl. 1987. PMID: 3475771 Clinical Trial.
A prospective randomized trial has been conducted for half a year comparing Sucralfate with a placebo in patients with symptomatological and macroscopical gastritis. Although approximately one hundred patients met the endoscopic criteria, the vast majority could not be inc …
A prospective randomized trial has been conducted for half a year comparing Sucralfate with a placebo in patients with symptomatologi …
Radiodermatitis prevention with sucralfate in breast cancer: fundamental and clinical studies.
Falkowski S, Trouillas P, Duroux JL, Bonnetblanc JM, Clavère P. Falkowski S, et al. Support Care Cancer. 2011 Jan;19(1):57-65. doi: 10.1007/s00520-009-0788-y. Epub 2009 Dec 9. Support Care Cancer. 2011. PMID: 19998046 Clinical Trial.
The clinical effects of sucralfate lotion were evaluated on 21 women treated for breast cancer. ...The sucralfate-containing lotion used in the present study did not provide systematic radiodermatitis prevention. ...
The clinical effects of sucralfate lotion were evaluated on 21 women treated for breast cancer. ...The sucralfate-containing l …
Sucralfate for posttonsillectomy analgesia.
Ozcan M, Altuntaş A, Unal A, Nalça Y, Aslan A. Ozcan M, et al. Otolaryngol Head Neck Surg. 1998 Dec;119(6):700-4. doi: 10.1016/S0194-5998(98)70040-3. Otolaryngol Head Neck Surg. 1998. PMID: 9852554 Clinical Trial.
Tonsillectomy leaves two large ulcerous wounds, and sucralfate may bind those wounds as it does peptic ulcers. In this controlled study, the efficacy of sucralfate on posttonsillectomy throat pain, otalgia, analgesic requirement, degree of strength, bleeding, body t …
Tonsillectomy leaves two large ulcerous wounds, and sucralfate may bind those wounds as it does peptic ulcers. In this controlled stu …
Randomised double blind placebo controlled clinical trial of sucralfate and ranitidine in chronic duodenal ulcer.
Nair KV, Ramachandran TM, Thomas V, Rajindranath T. Nair KV, et al. J Assoc Physicians India. 1990 Mar;38(3):211-2. J Assoc Physicians India. 1990. PMID: 2202705 Clinical Trial.
A double blind, randomised, placebo controlled clinical trial was carried out in endoscopically proved chronic duodenal ulcer patients to compare the efficacy of sucralfate and ranitidine. Sucralfate 1 g four times daily and ranitidine 150 mg twice daily were found …
A double blind, randomised, placebo controlled clinical trial was carried out in endoscopically proved chronic duodenal ulcer patients to co …
Stress bleeding prophylaxis with sucralfate. Pathophysiologic basis and clinical use.
Tryba M. Tryba M. Scand J Gastroenterol Suppl. 1990;173:22-33. doi: 10.3109/00365529009091920. Scand J Gastroenterol Suppl. 1990. PMID: 1693444 Review.
Most intensive care patients show a reduced acid secretion, a reduction of the gastric mucosal blood flow, and a decreased mucus and bicarbonate secretion. Sucralfate enhances most of the defensive mechanisms. These actions are the pathophysiologic basis of the efficacy of …
Most intensive care patients show a reduced acid secretion, a reduction of the gastric mucosal blood flow, and a decreased mucus and bicarbo …
Clinical efficacy of sucralfate in reflux oesophagitis.
Tytgat GN. Tytgat GN. Scand J Gastroenterol Suppl. 1987;140:29-31. Scand J Gastroenterol Suppl. 1987. PMID: 3328282 Review.
Hameeteman et al (7) found improvement of esophagitis in 53% and healing in 31% after sucralfate, compared with 67% and 14% respectively after cimetidine. ...Simon et al (8) found endoscopic healing in 64% and improvement in 27% of sucralfate-healed patients, compar …
Hameeteman et al (7) found improvement of esophagitis in 53% and healing in 31% after sucralfate, compared with 67% and 14% respectiv …
Evaluation of the efficacy of topical sucralfate on healing haemorrhoidectomy incision wounds and reducing pain severity: A randomised clinical trial.
Vejdan AK, Khosravi M, Amirian Z, Daneshmand M, Babak B, Samira K, Azin S, Kosar S, Razie K. Vejdan AK, et al. Int Wound J. 2020 Aug;17(4):1047-1051. doi: 10.1111/iwj.13369. Epub 2020 Apr 21. Int Wound J. 2020. PMID: 32319175 Free PMC article. Clinical Trial.
Antibiotics and topical agents, such as solutions and ointments, have been evaluated. The current research investigates the effects of sucralfate ointment on wound healing (epithelialisation) and postoperative pain after open haemorrhoidectomy. This trial involves two grou …
Antibiotics and topical agents, such as solutions and ointments, have been evaluated. The current research investigates the effects of su
The efficacy, safety and dosage of sucralfate in ulcer therapy.
Marks IN. Marks IN. Scand J Gastroenterol Suppl. 1987;140:33-8. Scand J Gastroenterol Suppl. 1987. PMID: 3328283 Review.
The DU relapse rate after sucralfate healing is perhaps lower than after cimetidine healing, and sucralfate healing rates in DU are not compromised by concomitant cimetidine therapy, or by smoking. ...Sucralfate is effective in the prevention of GU relapse in …
The DU relapse rate after sucralfate healing is perhaps lower than after cimetidine healing, and sucralfate healing rates in D …
Clinical studies of sucralfate in reflux esophagitis. The European experience.
Hameeteman W. Hameeteman W. J Clin Gastroenterol. 1991;13 Suppl 2:S16-20. J Clin Gastroenterol. 1991. PMID: 1885899 Review.
Sucralfate is comparable to H2-receptor antagonists in symptom improvement and healing rates. In addition, the studies reviewed have shown sucralfate to be safe and well tolerated....
Sucralfate is comparable to H2-receptor antagonists in symptom improvement and healing rates. In addition, the studies reviewed have
471 results